Press Releases
Search
-
15 Apr 2008
bioMérieux Bestowed 2007 Frost & Sullivan European Healthcare-Associated Infection Control Technology Leadership Award
April 15, 2008. The 2007 European Healthcare-Associated Infection Control Technology Leadership Award is conferred upon bioMérieux in recognition of its unparalleled leadership and commitment toward h...
-
03 Apr 2008
University of Sunderland and bioMérieux Collaborate in New Research Significantly Improving the Identification of Pseudomonas aeruginosa. A Major Cause of Death in Cystic Fibrosis Patients
April 3, 2008 . A team of researchers from the University of Sunderland and bioMérieux, a leading company in the field of in vitro diagnostics, have achieved a new step in the fight against Pseudomona...
-
17 Mar 2008
2007 Financial Results
March 17, 2008. 2007: Clear improvement in growth and in operating margin before non-recurring items...
-
17 Mar 2008
bioMérieux and Hitachi High-Technologies Corporation Enter into Long-Term Strategic Partnership Focus on Microbiology and Molecular Diagnostics
March 17, 2008 . bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics has entered into a long-term strategic partnership with Hitachi High-Technologies Corporation of Japan.
-
13 Mar 2008
FDA Clears bioMérieux’s VIDAS® NT-proBNP
A High Medical Value Test for Diagnosis of Heart Failure March 13, 2008 . bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. F...
-
06 Mar 2008
bioMérieux Opens New Subsidiary in Singapore
March 6, 2008. bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, announces the opening of a subsidiary in Singapore. This 38th subsidiary is another milestone for the co...